Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Thompson Peter A
Relationship:   Director
City:   Bellevue
State:   WA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   385,419    

Indirect Shares

   41,741,947      
Direct Value   $0    

Indirect Value

   $304,920,542      
Total Shares   42,127,366      
Total Value   $304,920,542      


Trubion Pharmaceuticals, Inc $0 Trubion Pharmaceuticals, Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    4    

     Stock price went up :
    1   
    2    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   19.0%
 340.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Trubion Pharmaceuticals, Inc TRBN President and CEO, Dir... 2009-05-22 385,419 2009-05-22 1,000    Premium*  
            Sierra Oncology Inc SRRA Director 2015-07-21 0 2015-07-21 1,989,949    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director 0 2018-06-06 4,901,310    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS Director, 10% Owner 2016-03-29 0 2021-09-20 6,943,654    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2017-07-24 0 2024-01-11 2,680,496    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Prevail Therapeutics Inc. PRVL Director, 10% Owner 0 2021-01-22 0    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP Director, 10% Owner 2020-09-29 0 2020-09-29 114,039    Premium*  
            Silverback Therapeutics, Inc. SBTX Director 0 2023-08-29 9,240,887    Premium*  
            Decibel Therapeutics, Inc. DBTX Director, 10% Owner 2021-02-17 0 2021-02-17 883,418    Premium*  
            Edgewise Therapeutics, Inc. EWTX Director, 10% Owner 0 2024-01-23 14,756,096    Premium*  
            Janux Therapeutics, Inc. JANX Director 2021-12-16 0 2021-12-29 231,098    Premium*  
* Premium Members only  

Records found :    71         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-10 4 B $12.98 $259,600 I/I 20,000 5,319,966 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-14 4 B $12.71 $127,100 I/I 10,000 5,329,966 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-15 4 B $11.94 $59,700 I/I 5,000 5,334,966 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-16 4 B $12.04 $60,200 I/I 5,000 5,339,966 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-17 4 B $12.48 $153,504 I/I 12,300 5,352,266 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-21 4 B $12.87 $335,688 I/I 26,083 5,378,349 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-23 4 B $12.92 $1,292 I/I 100 5,378,449 2.17 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-24 4 B $12.99 $11,691 I/I 900 5,379,349 2.17 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2018-03-12 4 B $8.50 $4,999,998 I/I 588,235 5,967,584 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2019-06-27 4 B $3.34 $109,963 I/I 32,923 6,000,507 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2019-06-28 4 B $3.72 $2,102,462 I/I 565,178 6,565,685 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2019-07-01 4 B $3.91 $231,640 I/I 59,243 6,624,928 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2019-08-06 4 B $3.51 $500,723 I/I 142,656 6,767,584 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2021-02-17 4 B $3.50 $4,499,999 I/I 1,285,714 8,053,298 2.25 %
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2021-09-20 4 S $6.09 $6,757,732 I/I (1,109,644) 6,943,654 0 %
DBTX Decibel Therapeutics, Inc... Director   –       •       •   2021-02-17 4 A $0.00 $0 I/I 3,278,526 218,568 0 -
DBTX Decibel Therapeutics, Inc... Director   –       •       •   2021-02-17 4 B $18.00 $29,999,988 I/I 1,666,666 883,418 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-25 3 IO $0.00 $0 I/I 0 316,920 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-30 4 B $16.00 $5,750,000 I/I 359,375 13,359,456 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-30 4 A $0.00 $0 I/I 13,002,760 272,724 0 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2022-05-18 4 B $7.21 $994,980 I/I 138,000 13,497,456 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2022-09-16 4 B $10.32 $4,999,999 I/I 484,496 13,981,952 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2024-01-23 4 B $11.00 $4,999,995 I/I 454,545 14,436,497 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-16 4 S $19.07 $7,500,231 I/I (393,300) 245,898 0 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-21 4 S $19.00 $2,268,600 I/I (119,400) 234,798 0 -
  71  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us